| 51.66 Delayed Data As of Aug 16 |  +1.37 / +2.72%Today’s Change | 41.23 Today|||52-Week Range 52.83 | +12.13% Year-to-Date |
| Top Stock Reports for Cisco, Medtronic & Novo Nordisk Aug 16 / Zacks.com - Paid Partner Content | Pharma Stock Roundup: AGN, NVO Earnings, EU Nod to SNY & ABBV Drugs for New Patients Aug 09 / Zacks.com - Paid Partner Content |
| Novo Nordisk Waits for Its Next Launch Aug 15 / MotleyFool.com - Paid Partner Content | Novo Nordisk (NVO) Q2 Earnings & Revenues Beat Estimates Aug 09 / Zacks.com - Paid Partner Content |
| Why Earnings Season Could Be Great for Novo Nordisk (NVO) Aug 12 / Zacks.com - Paid Partner Content | NVS vs. NVO: Which Stock Should Value Investors Buy Now? Aug 08 / Zacks.com - Paid Partner Content |
| Previous close | 50.29 |
| Today’s open | 51.30 |
| Day’s range | 51.11 - 51.68 |
| Volume | 1,688,083 |
| Average volume (3 months) | 1,478,869 |
| Market cap | $93.3B |
| Earnings growth (last year) | +8.07% |
| Earnings growth (this year) | +0.93% |
| Earnings growth (next 5 years) | +9.40% |
| Revenue growth (last year) | +4.51% |
| P/E ratio | 22.2 |
| Price/Sales | 6.31 |
| Price/Book | 15.56 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | +1.45 | +2.30% |
| GSKGlaxoSmithKline | +0.23 | +0.58% |
| SNYSanofi | +0.37 | +0.89% |
| LLYEli Lilly and Co | +0.29 | +0.26% |
| Next reporting date | November 1, 2019 |
| EPS forecast (this quarter) | $0.61 |
| Annual revenue (last year) | $17.7B |
| Annual profit (last year) | $6.1B |
| Net profit margin | 34.54% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
President & Chief Executive Officer Lars Fruergaard Jørgensen |
Executive Vice President- International Operations Maziar Mike Doustdar |
Corporate headquarters Bagsværd, Capital Region |
